Civica
Financial intelligence for Asia's healthcare markets
 
 
Remember me:

Analysis: Quadria boosts Asian investments

Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.

In Vietnam, it has completed an investment in HCM City-based FV Hospital. Founded by Jean-Marcel Guillon in 2003, the 220-bed hospital has more than 950 service staff, including 130 Vietnamese and expatriate doctors. It is the only joint commission international accredited hospital in South Vietnam. It also operates an outpatient clinic at the heart of District 1, HCM City’s traditional business district.

The investment will be used to build leading diagnostic and treatment centres for selected specialties and to provide access to advanced care in Central and South Vietnam via establishing an integrated network of healthcare facilities across the region.

Other investors who participated in the investment with Quadria include funds managed by Neuberger Berman Private Equity and DEG, the German development finance institution and a subsidiary of KfW.

In Singapore, it has taken a significant stake in MWH Holdings, the holding company for the Singapore Heart, Stroke and Cancer Centre. MWH currently operates out of Paragon Medical Centre and will be expanding its operations this year with a new centre located at Royal Square Novena.

It currently operates under four flagship brands: Singapore Heart, Stroke and Cancer Centre, a specialist centre focused on prevention, early diagnosis and treatment of heart disease, stroke and cancer; Singapore Medical Specialists Centre – multi-specialist centre offering a comprehensive range of specialty care services; Singapore Centre for Medical Imaging, a radiology centre offering a wide range of latest high-end diagnostics modalities; and Face, Body and Skin Aesthetics Medical Center, an aesthetics centre offering non-invasive, minimally invasive and surgical proceedures.

“Whilst we continue to serve the domestic and medical tourism segment out of Singapore, we see a significant opportunity regionally, particularly in the mid-tier segment where patients require something more affordable or for certain conditions where patients are unable to travel for treatment,” said Michael Lim, chief medical officer of MWH. And Quadria will support MWH’s regional growth ambitions through its existing hospital network and relationships.

Quadria Capital has assets exceeding US$1.5 billion and investments in 15 companies across the AsiaPacific region. It closed its third Quadria Capital Fund at US$304 million in June 2015 with two investments in Medica Synergie, the largest hospital network in eastern India, and SOHO Global Health, one of the largest pharmaceutical manufacturing and distribution businesses in Indonesia. The investments in Vietnam and Singapore are the sixth and seventh investments from that fund.

Posted on: 12/07/2017 UTC+08:00


News

Union Medical Healthcare, the largest aesthetic medical service provider in Hong Kong, has said that it intends to change the use of the proceeds of its IPO.
Hong Kong-listed Hua Han Health Industry Holdings says that it is on course for the examination into the negative reports from Emerson Analytics last year to be completed by Grant Thornton by the end of the third quarter.
Hang Seng-listed China Medical & HealthCare Group expects to record a significant decrease in the loss attributable to the shareholders of the company for the year ended 30 June.
Beijing-based Symbow Medical, which develops surgical navigation devices, has raised Rmb120 million (US$17.8 million) Series A funding led by Huayi Capital. National Emerging Industry Guidance Fund, Shandong Buchang Pharmaceuticals, and Sangel Capital all participated.
International Healthway Corporation (IHC), a Singapore-listed integrated healthcare services and facilities provider, has warned that it expects to post a loss for the first and second quarters of the year. “The loss is mainly attributable to operating loss for 1Q2017 and impairment of certain receivables for 2Q2017, respectively,” the company said in a statement.
Medical glove manufacturer Careplus Group plans to raise M$18.9 million (US$4.4 million) via a private placement of shares. The group plans to sell 48.3 million shares at an indicative price of R$0.39 per share. RHB Investment Bank is managing the deal.
Private investment firm TE Asia Healthcare Partners and the Mother Teresa of Calcutta Medical Centre (MTCMC) in Pampanga have agreed to establish a Ps500 million (US$9.9 million) cancer treatment and management centre. The hospital is owned and operated by Silvermed Corporation.
Medical centre operator Primary Health Care has confirmed guidance for the year at the lower end of its guidance with expected net profits of A$92 million (US$73 million). It also flagged up a write down of A$575 million against its medical centres as the division has been underperforming.



Analysis

In what is starting to resemble a comedy of errors, Wenzhou Kangning Hospital, the largest private psychiatric specialty care service provider in China, is having to start work yet again for its A-share offering.
Singapore-based private equity firm Quadria Capital is expanding its holdings in the region with investments into Vietnam and Singapore from its third investment vehicle, Quadria Capital Fund. Financial details were not disclosed for either transaction.
Mental health is a growing issue for expats; workers and their employers, as well as those relocating independently, according to a recent research study by Aetna International. Expatriate mental health: breaking the silence and ending the stigma, calls for businesses and individuals to take more pre-emptive action to combat the problem, to ensure expats have the vital support they need when relocating or working away from their home country.
A new programme, launched by the Chinese Stroke Association (CSA) and the American Stroke Association (ASA) is aiming to improve the treatment for, and prevention of, cardiovascular and stroke events by helping hospitals and providers consistently adhere to the latest scientific treatment guidelines.
Brisbane-based Oventus has had a good week. First and foremost the sleep disorder device manufacturer has just completed the first tranche of capital raising. It has raised A$6.5 million (US$4.9 million) in a placement of shares at A$0.36 per share. A second tranche to raise A$0.5 million will follow subject to shareholder approval. Bell Potter is managing the deal.
A new report from QBE Insurance, Australia's largest global insurer, reveals that 22% of healthcare companies in Hong Kong have suffered from legal and regulatory compliance issues over the past 12 months. The Risks of Regret report looks at both current and future business challenges and opportunities, and how well-prepared companies are to deal with risks.
“The Asia-Pacific region presents lucrative opportunities for multinational pharmaceutical firms that treat diabetes,” says BMI Research in Singapore in a new report on healthcare in Asia. Fuelled by rapid urbanisation, nutrition transition and increasingly sedentary lifestyles, the epidemic has grown in parallel with the worldwide rise in obesity. Asia’s large population and rapid economic development have made it an epicentre of the epidemic, with India and China the key hotspots in the region, it explains.
Susann Roth, senior social development specialist, Asian Development Bank, explains why the ADB is committed to doubling health sector investments by 2020.


AON

HealthInvestor Asia Summit

Podcasts

Hedge Fund Focus

HealthInvestor Asia twitter feed
HIA Indices